Cadila submits NDA for treatment of anaemia

Cadila submits NDA for treatment of anaemia

by admin- Tuesday, November 23rd, 2021 04:12:32 PM

Zydus Cadila has submitted the New Drug Application (NDA) to the Drug Controller General of India for Desidustat, an oral small molecule hypoxia-inducible thing prolyl hydroxylase (HIF-PH) inhibitor for remedy of anaemia in patients with Chronic Kidney Disease (CKD) who are on Dialysis and Not on Dialysis.

News Updates